Literature DB >> 33914889

Distal Renal Tubular Acidosis: ERKNet/ESPN Clinical Practice Points.

Francesco Trepiccione1, Steven B Walsh2, Gema Ariceta3, Olivia Boyer4, Francesco Emma5, Roberta Camilla6, Pietro Manuel Ferraro7,8, Dieter Haffner9, Martin Konrad10, Elena Levtchenko11, Sergio Camilo Lopez-Garcia2,12, Fernando Santos13, Stella Stabouli14, Maria Szczepanska15, Velibor Tasic16, Rezan Topaloglu17, Rosa Vargas-Poussou18, Tanja Wlodkowski19, Detlef Bockenhauer10,11.   

Abstract

Distal renal tubular acidosis (dRTA) is characterised by an impaired ability of the distal tubule to excrete acid, leading to metabolic acidosis. Associated complications include bone disease, growth failure, urolithiasis and hypokalaemia. Due to its rarity, there is a limited evidence to guide diagnosis and management, however, available data strongly suggest that metabolic control of the acidosis by alkali supplementation can halt or revert almost all complications. Despite this, cohort studies show that adequate metabolic control is present in only about half of patients, highlighting problems with treatment provision or adherence. With these clinical practice points the authors, part of the working groups tubulopathies in the European Rare Kidney Disease Reference network (ERKnet) and inherited kidney diseases of the European Society for Paediatric Nephrology (ESPN) aim to provide guidance for the management of patients with dRTA to facilitate adequate treatment and establish an initial best practice standard against which treatment of patients can be audited.
© The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  ATP6V0A4; ATP6V1B1; FOXI1; SLC4A1; WDR72; acidosis; distal renal tubular acidosis; nephrocalcinosis; urolithiasis

Year:  2021        PMID: 33914889     DOI: 10.1093/ndt/gfab171

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  A clinical approach to tubulopathies in children and young adults.

Authors:  Andrew Mallett; Hugh McCarthy; Rachael Kermond
Journal:  Pediatr Nephrol       Date:  2022-05-18       Impact factor: 3.714

Review 2.  Long-term complications of primary distal renal tubular acidosis.

Authors:  Fernando Santos; Helena Gil-Peña
Journal:  Pediatr Nephrol       Date:  2022-05-11       Impact factor: 3.714

3.  Improved growth of a child with primary distal renal tubular acidosis after switching from a conventional alkalizing treatment to a new prolonged-release formulation containing potassium citrate and potassium bicarbonate: lessons for the clinical nephrologist.

Authors:  Olivia Boyer; Maria A Manso-Silván; Sophie Joukoff; Romain Berthaud; Catherine Guittet
Journal:  J Nephrol       Date:  2022-03-31       Impact factor: 4.393

4.  Whole-exome sequencing and variant spectrum in children with suspected inherited renal tubular disorder: the East India Tubulopathy Gene Study.

Authors:  Rajiv Sinha; Subal Pradhan; Sushmita Banerjee; Afsana Jahan; Shakil Akhtar; Amitava Pahari; Sumantra Raut; Prince Parakh; Surupa Basu; Priyanka Srivastava; Snehamayee Nayak; S G Thenral; V Ramprasad; Emma Ashton; Detlef Bockenhauer; Kausik Mandal
Journal:  Pediatr Nephrol       Date:  2022-01-10       Impact factor: 3.651

5.  Distal Renal Tubular Acidosis Associated with Autoimmune Diseases: Reports of 3 Cases and Review of Mechanisms.

Authors:  Marcelo Augusto Duarte Silveira; Antônio Carlos Seguro; Samirah Abreu Gomes; Maria Helena Vaisbich; Lúcia Andrade
Journal:  Am J Case Rep       Date:  2022-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.